LOXL1 and prostate carcinoma: A different research found that the long noncoding RNAs EGFR and LOXL1-AS1were expressed at a low level, but the doxorubicin-resistant prostate cancer DU-145 cells exhibited an overexpression of the microRNA miR-let-7a-5p.